Literature DB >> 16944190

Differential immunogold localisation of sulphated and unsulphated keratan sulphate proteoglycans in normal and macular dystrophy cornea using sulphation motif-specific antibodies.

Robert D Young1, Tomoya O Akama, Petra Liskova, Neil D Ebenezer, Bruce Allan, Briedgeen Kerr, Bruce Caterson, Michiko N Fukuda, Andrew J Quantock.   

Abstract

Keratan sulphate (KS) proteoglycans (PGs) are key molecules in the corneal stroma for tissue organisation and transparency. Macular corneal dystrophy (MCD) is a rare, autosomal recessive disease characterised by disturbances in KS expression. MCD is caused by mutations in CHST6, a gene encoding the enzyme responsible for KS sulphation. Sulphated KS is absent in type I disease causing corneal opacity and loss of vision. Genetic studies have highlighted the mutational heterogeneity in MCD, but supportive immunohistochemical studies on corneal KS have previously been limited by the availability of antibodies mostly reactive only with highly sulphated KS epitopes. In this study, we employed four antibodies against specific KS sulphation patterns, including one against unsulphated KS, to investigate their reactivity in a case of MCD compared with normal cornea using high-resolution immunogold electron microscopy. Mutation analysis indicated type I MCD with deletion of the entire open reading frame of CHST6. Contrast enhanced fixation revealed larger PG structures in MCD than normal. Unlike normal cornea, MCD cornea showed positive labelling with antibody to unsulphated KSPG, but was negative with antibodies to sulphated KSPG. These antibodies will thus facilitate high-resolution investigations of phenotypic heterogeneity in support of genetic studies in this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944190     DOI: 10.1007/s00418-006-0228-8

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  20 in total

1.  Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype.

Authors:  G K Klintworth; E Oshima; A al-Rajhi; A al-Saif; E J Thonar; Z A Karcioglu
Journal:  Am J Ophthalmol       Date:  1997-07       Impact factor: 5.258

2.  Allelic heterogeneity of the carbohydrate sulfotransferase-6 gene in patients with macular corneal dystrophy.

Authors:  A Sultana; M S Sridhar; G K Klintworth; D Balasubramanian; C Kannabiran
Journal:  Clin Genet       Date:  2005-11       Impact factor: 4.438

Review 3.  Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans.

Authors:  B Caterson; J E Christner; J R Baker; J R Couchman
Journal:  Fed Proc       Date:  1985-02

4.  The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series.

Authors:  H Mehmet; P Scudder; P W Tang; E F Hounsell; B Caterson; T Feizi
Journal:  Eur J Biochem       Date:  1986-06-02

5.  CHST6 mutations in North American subjects with macular corneal dystrophy: a comprehensive molecular genetic review.

Authors:  Gordon K Klintworth; Clayton F Smith; Brandy L Bowling
Journal:  Mol Vis       Date:  2006-03-10       Impact factor: 2.367

6.  Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene.

Authors:  T O Akama; K Nishida; J Nakayama; H Watanabe; K Ozaki; T Nakamura; A Dota; S Kawasaki; Y Inoue; N Maeda; S Yamamoto; T Fujiwara; E J Thonar; Y Shimomura; S Kinoshita; A Tanigami; M N Fukuda
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

Review 7.  Keratan sulfate: structure, biosynthesis, and function.

Authors:  J L Funderburgh
Journal:  Glycobiology       Date:  2000-10       Impact factor: 4.313

8.  Mutations in the CHST6 gene in patients with macular corneal dystrophy: immunohistochemical evidence of heterogeneity.

Authors:  Nobuko Iida-Hasegawa; Atushi Furuhata; Hiroo Hayatsu; Akira Murakami; Keiko Fujiki; Kiyoo Nakayasu; Atsushi Kanai
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-08       Impact factor: 4.799

9.  Synchrotron X-ray diffraction in atypical macular dystrophy.

Authors:  A J Quantock; K M Meek; E J Thonar; K K Assil
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

10.  Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican.

Authors:  S Chakravarti; T Magnuson; J H Lass; K J Jepsen; C LaMantia; H Carroll
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

View more
  15 in total

Review 1.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

Review 2.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

Review 3.  State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2008-11-05       Impact factor: 4.304

4.  Isolation of bovine corneal keratan sulfate and its growth factor and morphogen binding.

Authors:  Amanda Weyers; Bo Yang; Kemal Solakyildirim; Vienna Yee; Lingyun Li; Fuming Zhang; Robert J Linhardt
Journal:  FEBS J       Date:  2013-02-28       Impact factor: 5.542

Review 5.  Structural and biochemical aspects of keratan sulphate in the cornea.

Authors:  Andrew J Quantock; Robert D Young; Tomoya O Akama
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

6.  The P2X(7) receptor regulates proteoglycan expression in the corneal stroma.

Authors:  Courtney Mankus; Cheryl Chi; Celeste Rich; Ruiyi Ren; Vickery Trinkaus-Randall
Journal:  Mol Vis       Date:  2012-01-18       Impact factor: 2.367

7.  Novel mutations of CHST6 in Iranian patients with macular corneal dystrophy.

Authors:  Shiva Akbari Birgani; Zivar Salehi; Masoud Houshmand; Mohamad Javad Mohamadi; Leila Azizade Promehr; Zahra Mozafarzadeh
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

8.  Sulfation patterns of keratan sulfate in different macular corneal dystrophy immunophenotypes using three different probes.

Authors:  T Saito; K Nishida; J Nakayama; T O Akama; M N Fukuda; K Watanabe; A J Quantock; N Maeda; H Watanabe; Y Tano
Journal:  Br J Ophthalmol       Date:  2008-10       Impact factor: 4.638

9.  Naturally occurring and stress induced tubular structures from mammalian cells, a survival mechanism.

Authors:  Yonnie Wu; Richard C Laughlin; David C Henry; Darryl E Krueger; JoAn S Hudson; Cheng-Yi Kuan; Jian He; Jason Reppert; Jeffrey P Tomkins
Journal:  BMC Cell Biol       Date:  2007-08-16       Impact factor: 4.241

10.  A role for topographic cues in the organization of collagenous matrix by corneal fibroblasts and stem cells.

Authors:  Dimitrios Karamichos; Martha L Funderburgh; Audrey E K Hutcheon; James D Zieske; Yiqin Du; Jian Wu; James L Funderburgh
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.